Personal Information
Ocupación
Associate Professor Pharmacology
Sector
Education
Etiquetas
macrolides
chloramphenicol
fluoroquinolones
mechanism of action
yellow card blue card
adverse drug reaction
clinical trials
thalidomide disaster
who
prevention
understanding
assessment
detection
pharmacovigilance
stirrup
hammer
anvil
ear drum
semicircular canal
cranial nerve
vestibule
cochlea
eustachian tube
round window
oval window
stapes
incus
malleus
tympanic membrane
external auditory canal
inner
middle
outer
the_human_ear
epinephrine
tyrosine
antihistaminics
amantadine
tolcapone
entacapone
rasagiline
selegiline
comt inhibitor
mao-b inhibitor
ropinirole
bromocriptyne
benserazid
carbidopa
levodopa
antiparkinson drug
mesolimbic pathway
nigrostriatal pathway
epinephrine histamine serotoni
dopamine norepinephri
gases
lipids
purines
neuropeptides
amino acids
aspartate
glutamate
glycine
gaba
amino acids
norepinephrine
dopamine
atecholamines
histamine
monoamines - acetylcholine
hallucinogens
and testes.
ovaries
pancreas
thyroid gland
adrenal glands
pitutory glans
growth hormone
steroids
amino acid hormones
endocrine system
addiction
drugs abuse
cns stimulents
anesthetic classifications
action potential
local anesthetics
myasthenia gravis
skeletal muscle relaxants
peripherally acting
saddle
gliding
pivot
condyloid
hinge
skeletal system
joints
quinolones
dna gyrase inhibitors
enzyme-linked receptors
g-protein linked receptors
ion channels
metabotropic
inotropic
receptor classification
receptors
anticonvulsants
anti-epileptic drugs
body cavities
body plans
basic anatomical terminology
basic life process
homeostatic mechanism
scope
anatomy and physiology
anti-alzheimers drug
anti-anxity drugs
blood clotting
blood grouping
hematopoietic system-human blood
neurtransmeter
neuron
details about various routes for drug administrati
routes of drug adminstration factors for the choi
troduction to pharmacology defination scope histor
endogenous agonist super agonist full agonist part
agonists and antagonists ligands types of agonist
eries: efferent vessels capillaries: veins: affere
actinomycin
amphotericine b. 4. inhibitors of nucleic acid
nystatin
lincosamide 3. inhibitors of bacterial cell memb
tertacycline
cycloserine 2. inhibitors of protien synthesis:
bacitaeacin
cephalosporine
alexander fleming microbes make antibiotics e
other inflammatory bowel disease sulfasalaz
enteritis
gi infections (2) intestinal infections ulc
respiratory infections
1.systemic infections cerebral meningitis tympani
pharmacokinetics clinical uses
long acting (> 12 hrs) sulphadoxine - sulphameth
penetrates bbb- meningitis acetylated product is
systemic use i.short acting (4-8hrs) sulpha me
and some protozoa. sulphonamides (members)
chlamydia trachomatis
nocardia actinomyces
shigella others: bacillus anthracis
escherichia coli
gonococcus
g+ bacteria: group a streptococcus pyogenes str
broad-spectrum
trimethoprim (cotrimoxazole) as antibacterial pyri
the development of chemotherapy
tetracyclines
sulphonamides
quinolones (gaba antagonists)
molecular basis of chemotherapy
mechanisms of action of antibacterial drugs
drugs that inhibit nucleic acid synthesis nucleosi
biochemical reaction as potent targets
basic principles of chemotherapy
antiviral drugs
antimicrobial drugs
antibacterials – competitive inhibitors
aminoglycosides
gatifloxacin
lomefloxacin and pefloxacin
enoxacin
ofloxacin
levofloxacin
ciprofloxacin
norfloxacin
generations
topoisomerases
bactericidal
adverse effects
clinical uses
pharmacokinetics
mechanisms of resistance
classifications
antimicrobial activity
its structure
na gyrase inhibitors -quinolones
β -lactam antibiotics
classification
cephalosporins and development
human heart covering layers and wall
human heart conduction system
human heart basic functions
human heart anatomy and physiology
Ver más
- Presentaciones
- Documentos
- Infografías